Why you can't compare Covid-19 vaccines

6 325 848
16 days – 940 09422:17
How Racist Am I?
351 day – 2 527 7864:58
How coronavirus charts can mislead us
Published on 20 Mar 2021, 12:00
What a vaccine's "efficacy rate" actually means.

Sign up for our newsletter: vox.com/video-newsletter

In the US, the first two available Covid-19 vaccines were the ones from Pfizer/BioNTech and Moderna. Both vaccines have very high "efficacy rates," of around 95%. But the third vaccine introduced in the US, from Johnson & Johnson, has a considerably lower efficacy rate: just 66%.

Look at those numbers next to each other, and it's natural to conclude that one of them is considerably worse. Why settle for 66% when you can have 95%? But that isn't the right way to understand a vaccine's efficacy rate, or even to understand what a vaccine does. And public health experts say that if you really want to know which vaccine is the best one, efficacy isn't actually the most important number at all.

Further reading from Vox:

Why comparing Covid-19 vaccine efficacy numbers can be misleading: vox.com/22311625/covid-19-vacc...

The vaccine metric that matters more than efficacy: vox.com/22273502/covid-vaccine...

The limits of what vaccine efficacy numbers can tell us: vox.com/21575420/oxford-modern...

Vox.com is a news website that helps you cut through the noise and understand what's really driving the events in the headlines. Check out vox.com.

Watch our full video catalog: goo.gl/IZONyE
Follow Vox on Facebook: goo.gl/U2g06o
Or Twitter: goo.gl/XFrZ5H